17.04
-1.02
(-5.65%)
At close: April 17 at 4:00:00 PM EDT
16.15
-0.89
(-5.22%)
After hours: April 17 at 4:54:07 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BOUDREAU HELEN M. Director | Stock Award(Grant) | Jun 4, 2024 | 150,647 |
GONCALVES JOANA Officer | Sale | Apr 5, 2024 | 53,365 |
IVES JEFFREY L Director | Stock Award(Grant) | Jun 4, 2024 | 198,485 |
MAYNARD RYAN D Chief Financial Officer | Stock Award(Grant) | Feb 1, 2024 | 13,500 |
MENZAGHI FREDERIQUE Officer | Stock Award(Grant) | Feb 1, 2024 | 167,247 |
POSNER CHRISTOPHER Chief Executive Officer | Sale | Feb 28, 2025 | 13,109 |
SHIFF SUSAN Director | Stock Award(Grant) | Jun 4, 2024 | 202,085 |
TERRILLION SCOTT M General Counsel | Sale | Feb 28, 2025 | 7,190 |
VOGELBAUM MARTIN A Director | Stock Award(Grant) | Jun 4, 2024 | 411,007 |
VON MOLTKE LISA Director | Stock Award(Grant) | Jun 4, 2024 | 183,009 |
Related Tickers
CARA Cara Therapeutics, Inc.
5.32
-2.56%
KZIA Kazia Therapeutics Limited
3.3000
-6.59%
CHRO Channel Therapeutics Corporation
1.8400
+46.61%
APM Aptorum Group Limited
0.8313
-9.03%
IMRX Immuneering Corporation
1.2700
+1.60%
DWTX Dogwood Therapeutics, Inc.
4.2700
+14.48%
QNRX Quoin Pharmaceuticals, Ltd.
5.48
-7.46%
GRI GRI Bio, Inc.
1.5100
-1.31%
BCTX BriaCell Therapeutics Corp.
4.2900
-4.24%
SKYE Skye Bioscience, Inc.
1.4350
-9.18%